Search Within

David H Ilson

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
Groups
  1. Department of Medicine (15)
  2. Gastrointestinal Oncology Service (15)
  3. Molecular Imaging and Therapy Service (15)
  4. Radiology, Department of (15)
  5. Solid Tumor Oncology Division (15)
  6. Surgery (12)

More Groups

People
  1. Yelena Janjigian (12)
  2. Geoffrey Ku (9)
  3. Heiko Schoder (7)
  4. Laura Tang (7)
  5. Marinela Capanu (7)
  6. Abraham Wu (6)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Surgery (1)
  3. Annals of Surgical Oncology (1)
  4. British Journal of Cancer (1)
  5. Cancer Discovery (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Lippincott Williams & Wilkins (1)
  5. Nature Publishing Group (1)
  6. Pioneer Bioscience Publishing Company (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Trivedi, N.; Maron, S. B.; Joshi, S. S.; Ilson, D. H.; Janjigian, Y. Y.; Shcherba, M.; Li, J.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Durvalumab and PET-directed chemoradiation in locally advanced esophageal adenocarcinoma: A phase Ib/II study
    Journal Article

    Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results
    Meeting Abstract

    Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma
    Meeting Abstract

    Ly, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Gu, P.; Sugarman, R.; Maron, S. B.; Chalasani, S. B.; Shcherba, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: The Memorial Sloan Kettering Cancer Center experience
    Journal Article

    Won, E.; Shah, M. A.; Schòˆder, H.; Strong, V. E.; Coit, D. G.; Brennan, M. F.; Kelsen, D. P.; Janjigian, Y. Y.; Tang, L. H.; Capanu, M.; more...
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
    Journal Article

    Chhabra, A.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Prognostic significance of FDG-PET metrics in esophageal squamous cell carcinoma
    Meeting Abstract

    Chhabra, A. M.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save